Overview
The goal of this clinical trial is to set up a prospective, fit-for-purpose collection of human body material (HBM)-blood (serum, plasma, DNA) and tissue-and standardized clinical data of patients with cutaneous melanoma and non-melanoma skin cancer.
The main questions it aims to answer are:
- To create a biobank with samples of human body material (HBM): blood (serum/plasma/DNA) and tissue and clinical data of patients with cutaneous melanoma and non-melanoma.
- To support future research questions (after specific approval of the Ethics Committee) by using the biobank (through satellite protocols).
If there is a comparison group: Not applicable (umbrella protocol for collection only).
Participants will:
- Share demographics, medical and surgical history, risk factors.
- Complete Cancer Worry Scale questionnaire.
- Provide biological samples:
- Blood samples (serum, plasma, DNA).
- Tissue samples (residual tissue or additional biopsy if consented).
Eligibility
Inclusion Criteria:
- Voluntary written informed consent of the participant or their legally authorized representative has been obtained prior to any screening procedures
- Adult subjects (\>18 years of age) at time of enrolment.
- Subjects diagnosed with cutaneous melanoma or Non-melanoma skin cancer.
- Adult subjects able and willing to provide informed consent.
Exclusion Criteria:
- Subjects unable or not willing to provide informed consent.
- Pregnancy (or willing to become pregnant) is NOT an exclusion criteria (unless specified in the respective satellite protocols.